top of page
![SonomaEye-full-color-vector[2].png](https://static.wixstatic.com/media/bed00b_da20b9cc704044b0b048ac8ef9190470~mv2_d_3024_2195_s_2.png/v1/fill/w_177,h_123,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/SonomaEye-full-color-vector%5B2%5D.png)
Orbit/Oculoplastics
Friday, 3/17/2023
10:20 am - 11:50 am
Moderators: Natalie Anne Homer, MD, Ted Wladis, MD and Andrea Kossler, MD
10-12 minutes for each presentation and 6-8 minutes for discussion after each presentation
Topic: 2023 Targeted Therapies for Oculoplastic Disease
10:20 am – 10:38 am: Update on Orbital Inflammatory Disorders (Suzanne Freitag, MD)
10:38 am – 10:56 am: Therapeutic Advancements in Thyroid Eye Disease (Andrea Kossler, MD, FACS)
10:56 am – 11:14 am: IgG4 Disease and Management (Jacqueline Busingye, MD)
11:14 am – 11:32 am: Targeted Therapies for Orbital and Periorbital Malignancies (Daniel Rootman, MD, MS)
11:32 am – 11:50 am: New Discoveries in the Treatment of Rosacea: Phase 1 Data (Ted Wladis, MD)
bottom of page